Navigation Links
Swine flu experts gather at New York Academy of Sciences May 28
Date:5/27/2009

The very latest information on the 2009 swine influenza (H1N1) outbreak is the subject of a landmark afternoon symposium hosted by the New York Academy of Sciences on Thursday, May 28. Speakers will discuss the new recombinant virus, epidemiology, treatment, vaccine development and the public health implications of a worldwide pandemic.

Reservations are required to attend the conference, held from 12:30 p.m. to 5:30 p.m., at academy offices, 7 World Trade Center, 40th floor, 250 Greenwich St. at Barclay St. A reception will follow.

Two microbiologists/immunologists from New York Medical College are leading the symposium, which will focus on understanding the pathogenicity and transmission of the viruses to develop improved methods of prevention and control. Keynote speaker Edwin D. Kilbourne, M.D., emeritus professor, developed the first genetically engineered vaccine of any kind more than 30 years ago. He is an internationally recognized research scientist who has made significant contributions to the study and prevention of influenza and other viral diseases.

Doris Bucher, Ph.D., associate professor, whose laboratory in Valhalla is one of just three worldwide that reproduces "seed" viruses for the influenza vaccine, which begins the process of producing some 450 million doses of a new vaccine each year. Dr. Bucher is the symposium organizer.

Speakers include Michael Shaw, CDC Influenza Division; Dominick A. Iacuzio, Hoffman-La Roche, Inc.; Kanta Subbarao, NIH Laboratory of Infectious Diseases; John Treanor, University of Rochester School of Medicine and Dentistry; Philip R. Dormitzer, Novartis Vaccines; Scott Harper, New York City Department of Health and Mental Hygiene; and James Matthews, Sanofi Pasteur, moderator.


'/>"/>

Contact: Donna E. Moriarty, M.P.H.
donna_moriarty@nymc.edu
914-439-5989
New York Medical College
Source:Eurekalert

Page: 1

Related biology news :

1. Contrast agent trials in swine
2. Improving swine waste fertilizer
3. Study finds MRSA in Midwestern swine, workers
4. Avian flu research sheds light on swine flu outbreak
5. K-State researcher finds 1918 flu resulted in current lineage of H1N1 swine influenza viruses
6. Swine flu genes dissimilar to past pandemics
7. HudsonAlpha investigator develops rapid response swine flu test
8. Swine flu: What does it do to pigs?
9. Leading experts cite poor health and nutrition as major barrier to education in developing world
10. Improving science, technology in Africa is aim as G-8, African, UN experts convene in Berlin
11. Less Arctic ice means higher risks, experts warn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
(Date:3/17/2016)... 17, 2016 ABI Research, the leader ... global biometrics market will reach more than $30 ... from 2015. Consumer electronics, particularly smartphones, continue to ... anticipated to reach two billion shipments by 2021 ... Pavlakis , Research Analyst at ABI Research. "Surveillance ...
Breaking Biology News(10 mins):
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located ... foot office building is complete. The new structure adds a third office building to ... Paar USA purchased 2.4 acres of land, along with office space adjacent to ...
(Date:5/19/2016)... , May 19, 2016 There ... fully recover given the relentless pressures in pricing and ... in the investors circle though - numerous opportunities are ... of today,s session, ActiveWallSt.com,s presents four names in this ... Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ), Anthera ...
(Date:5/19/2016)... , May 19, 2016 ... and (OTC PINK: RGBPP) announced today initiation of ... first cord blood based cancer immunotherapeutic product leveraging ... application, Regen described a generation of cord blood ... by gene silencing.  The product in development will ...
(Date:5/18/2016)... (PRWEB) , ... May 18, 2016 , ... Tech ... the Luis Villalobos Award to Cognition Therapeutics at the annual ACA Summit last week ... that is financed by one of ACA’s member angel groups. It is the highest ...
Breaking Biology Technology: